NovaBay Book Value Per Share from 2010 to 2025

NBY Stock

USD 0.61 0.01 1.53%

NovaBay Pharmaceuticals Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 30.06 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of NovaBay Pharmaceuticals according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

31.65

Current Value

30.06

Quarterly Volatility

141.56754765

Credit Downgrade

Yuan Drop

Covid

Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 229.5 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0638, Dividend Yield of 0.0 or PTB Ratio of 0.28. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of NovaBay Pharmaceuticals Correlation against competitors.

For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Latest NovaBay Pharmaceuticals' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of NovaBay Pharmaceuticals over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. NovaBay Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.22 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

NovaBay Book Value Per Share Regression Statistics

	Arithmetic Mean	226.69
	Geometric Mean	164.53
	Coefficient Of Variation	62.45
	Mean Deviation	113.43
	Median	207.37
	Standard Deviation	141.57
	Sample Variance	20,041
	Range	403
	R-Value	(0.36)
	Mean Square Error	18,757
	R-Squared	0.13
	Significance	0.18
	Slope	(10.58)
	Total Sum of Squares	300,621

NovaBay Book Value Per Share History

	2025	30.06
	2024	31.65
	2023	27.52
	2022	351.79
	2021	321.5
	2020	430.2
	2019	59.81

Other Fundumenentals of NovaBay Pharmaceuticals

Tangible Book Value Per Share

NovaBay Pharmaceuticals Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Total Liab	Net Debt	Retained Earnings	Accounts Payable	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Net Receivables	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.83	0.45	-0.61	-0.21	-0.17	0.86	0.6	0.22	-0.09	0.0	-0.25	0.19	0.2	-0.16	-0.38	0.11	0.47	0.49	0.18
Total Stockholder Equity	0.83		-0.11	-0.76	0.0	-0.41	0.88	0.63	0.24	0.08	-0.19	-0.1	0.59	0.05	-0.33	-0.39	0.21	0.51	0.53	0.15
Total Liab	0.45	-0.11		0.06	-0.33	0.36	0.15	0.11	-0.07	-0.28	0.25	-0.28	-0.58	0.25	0.24	-0.02	-0.13	0.04	0.07	0.03
Net Debt	-0.61	-0.76	0.06		-0.42	0.25	-0.87	-0.52	0.29	0.11	0.16	0.22	-0.7	0.37	0.19	0.11	-0.58	-0.3	-0.41	0.42
Retained Earnings	-0.21	0.0	-0.33	-0.42		-0.11	0.12	-0.05	-0.47	0.09	-0.09	0.03	0.53	-0.95	-0.05	0.32	0.49	-0.4	-0.25	-0.68
Accounts Payable	-0.17	-0.41	0.36	0.25	-0.11		-0.31	0.1	0.14	-0.66	0.25	-0.5	-0.7	0.05	0.04	-0.18	0.08	-0.19	-0.16	0.16
Total Current Assets	0.86	0.88	0.15	-0.87	0.12	-0.31		0.53	0.03	-0.06	-0.03	-0.25	0.53	-0.12	-0.15	-0.12	0.31	0.3	0.35	-0.13
Common Stock	0.6	0.63	0.11	-0.52	-0.05	0.1	0.53		0.08	-0.24	0.07	-0.3	0.1	0.09	-0.58	-0.36	0.17	0.53	0.55	0.25
Property Plant Equipment	0.22	0.24	-0.07	0.29	-0.47	0.14	0.03	0.08		-0.13	0.23	-0.31	-0.25	0.44	-0.1	-0.44	-0.23	-0.06	-0.15	0.82
Current Deferred Revenue	-0.09	0.08	-0.28	0.11	0.09	-0.66	-0.06	-0.24	-0.13		-0.71	0.89	0.3	-0.04	0.13	0.4	-0.5	-0.04	-0.04	-0.02
Short Term Debt	0.0	-0.19	0.25	0.16	-0.09	0.25	-0.03	0.07	0.23	-0.71		-0.71	-0.27	0.01	-0.19	-0.04	0.17	-0.26	-0.33	0.09
Net Receivables	-0.25	-0.1	-0.28	0.22	0.03	-0.5	-0.25	-0.3	-0.31	0.89	-0.71		0.14	0.03	0.11	0.36	-0.49	0.04	0.03	-0.08
Net Tangible Assets	0.19	0.59	-0.58	-0.7	0.53	-0.7	0.53	0.1	-0.25	0.3	-0.27	0.14		-0.44	-0.11	0.03	0.43	0.16	0.22	-0.43
Capital Surpluse	0.2	0.05	0.25	0.37	-0.95	0.05	-0.12	0.09	0.44	-0.04	0.01	0.03	-0.44		0.0	-0.37	-0.47	0.47	0.33	0.72
Deferred Long Term Liab	-0.16	-0.33	0.24	0.19	-0.05	0.04	-0.15	-0.58	-0.1	0.13	-0.19	0.11	-0.11	0.0		0.18	0.13	-0.13	-0.11	-0.08
Short Long Term Debt	-0.38	-0.39	-0.02	0.11	0.32	-0.18	-0.12	-0.36	-0.44	0.4	-0.04	0.36	0.03	-0.37	0.18		-0.34	-0.64	-0.64	-0.45
Cash And Equivalents	0.11	0.21	-0.13	-0.58	0.49	0.08	0.31	0.17	-0.23	-0.5	0.17	-0.49	0.43	-0.47	0.13	-0.34		0.14	0.26	-0.39
Net Invested Capital	0.47	0.51	0.04	-0.3	-0.4	-0.19	0.3	0.53	-0.06	-0.04	-0.26	0.04	0.16	0.47	-0.13	-0.64	0.14		0.98	0.24
Net Working Capital	0.49	0.53	0.07	-0.41	-0.25	-0.16	0.35	0.55	-0.15	-0.04	-0.33	0.03	0.22	0.33	-0.11	-0.64	0.26	0.98		0.12
Capital Stock	0.18	0.15	0.03	0.42	-0.68	0.16	-0.13	0.25	0.82	-0.02	0.09	-0.08	-0.43	0.72	-0.08	-0.45	-0.39	0.24	0.12

Click cells to compare fundamentals

About NovaBay Pharmaceuticals Financial Statements

NovaBay Pharmaceuticals investors use historical fundamental indicators, such as NovaBay Pharmaceuticals' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	31.65	30.06
Tangible Book Value Per Share	31.65	30.06

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC